GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects
Background
Major depression affects about 10 percent of the adult population and is the second leading cause of disability in U.S. adults, according to the World Health Organization. Despite the availability of several different classes of antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs), 30 to 40 percent of adults are unresponsive to these medications. Moreover, SSRIs typically take weeks to work, which increases the risk for suicide.
Enter NMDA (N-methyl-D-aspartate) receptor modulators. In the 1970s, researchers linked the receptors to learning and memory. Biotech and pharmaceutical companies in the 1980s attempted to apply chemical blockers to these receptors as a means to prevent stroke. But blocking these receptors led to the opposite effect—–the rise of cardiovascular disease. Research in the field dampened until a glutamate receptor antagonist already approved for anesthesia, and known on the streets as “Special K”, ketamine, made headlines in the early 2000s. Human clinical studies demonstrated that ketamine can ward off major and bipolar depressive symptoms within 2 hours of administration and last for several days. Ketamine is fraught with serious side effects including excessive sleepiness, hallucinations, and substance abuse behavior.
“Ketamine lit the field back up,“ said Joseph Moskal, Ph.D., a molecular neurobiologist at Northwestern University and senior study author. “Our drug, GLYX-13, is very different. It does not block the receptor ion channel, which may account for why it doesn’t have the same side effects.”
Moskal’s journey with GLYX-13 came about from his earlier days as a Senior Staff Fellow in NIMH’s Intramural Research Program. While at NIMH, he created specific molecules, monoclonal antibodies, to use as new probes to understand pathways of learning and memory. Some of the antibodies he created were for NMDA receptors. When he moved to Northwestern University, Moskal converted the antibodies to small protein molecules. Comprised of only four amino acids, GLYX-13 is one of these molecules.
Previous electrophysiological and conditioning studies had suggested that GLYX-13, unlike ketamine, enhanced memory and learning in rats, particularly in the brain’s memory hub or hippocampus. GLYX-13 also produced analgesic effects. Using several rat behavioral and molecular experiments, Moskal’s research team tested four compounds: GLYX-13, an inactive, “scrambled” version of GLYX-13 that had its amino acids rearranged, ketamine, and the SSRI fluoxetine.
Results of the Study
GLYX-13 and ketamine produced rapid acting (1 hour) and long-lasting (24 hour) antidepressant-like effects in the rats. Fluoxetine, an SSRI that typically takes from 2–4 weeks to show efficacy in humans, did not produce a rapid antidepressant effect in this study. As expected, the scrambled GLYX-13 showed no antidepressant-like effects at all. The researchers observed none of the aforementioned side effects of ketamine in the GLYX-13–treated rats.
Protein studies indicated an increase in the hippocampus of the NMDA receptor NR2B and a receptor for the chemical messenger glutamate called AMPA. Electrophysiology studies in this brain region showed that GLYX-13 and ketamine promoted long-lasting signal transmission in neurons, known as long-term potentiation/synaptic plasticity. This phenomenon is essential in learning and memory. The researchers propose how GLYX-13 works: GLYX-13 triggers NR2B receptor activation that leads to intracellular calcium influx and the expression of AMPA, which then is responsible for increased communication between neurons.
These results are consistent with data from a recent Phase 2 clinical trial, in which a single administration of GLYX-13 produced statistically significant reductions in depression scores in patients who had failed treatment with current antidepressants. The reductions were evident within 24 hours and persisted for an average of 7 days. After a single dose of GLYX-13, the drug’s antidepressant efficacy nearly doubled that seen with most conventional antidepressants after 4–6 weeks of dosing. GLYX-13 was well tolerated and it did not produce any of the schizophrenia-like effects associated with other NMDA receptor modulating agents.
The Latest Bing News on:
Major depression
- New device that emits magnetic field may offer hope for treating depressionon May 7, 2024 at 3:58 pm
In an exploratory clinical trial, four male patients diagnosed with major depressive disorder underwent eight weeks of treatment with a device that generates a low-frequency ultralow magnetic field ...
- Virtual Reality Shows Promise in Treating Depressionon May 6, 2024 at 2:18 pm
Summary: A new study demonstrates the potential of virtual reality (VR) in treating major depressive disorder (MDD). Using extended reality-enhanced behavioral activation (XR-BA), researchers found ...
- Beyond therapy: Virtual reality shows promise in fighting depressionon May 6, 2024 at 1:47 pm
A recent study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).
- Study sheds light on the promising role of virtual reality in treating depressionon May 6, 2024 at 11:55 am
A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).
- Depression Newson May 4, 2024 at 5:00 pm
Ketamine's Promise for Severe Depression Grows, but Major Questions Remain Feb. 8, 2024 — Using an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe ...
- Noninvasive Brain Stimulation Shows Rapid Relief for Major Depressionon May 2, 2024 at 8:19 am
An RCT suggests transcranial alternating current stimulation may be an effective treatment for major depression, but outside experts say more study is needed to confirm its benefit.
- What Fitness Exercises Treat Depression the Best?on May 2, 2024 at 6:36 am
Dance, exercise combined with medication, and walking or jogging were most effective for relieving symptoms of depression. Yoga, strength training, mixed aerobic exercises, and tai chi or qigong were ...
- Gilgamesh starts subject dosing in major depressive disorder trialon May 1, 2024 at 8:50 pm
Gilgamesh Pharmaceuticals has commenced subject dosing in a Phase IIa clinical trial of GM-1020 to treat major depressive disorder (MDD). This clinical trial aims to evaluate the safety, tolerability, ...
- Magnus Medical launches Saint neuromod system for major depressive disorder treatmenton May 1, 2024 at 9:43 am
Magnus Medical announced the commercial launch of its Saint neuromodulation system for treatment-resistant major depressive disorder (MDD).
- Why Depression Can Make It Hard to Know You're Depressedon April 29, 2024 at 8:05 am
Depression often leads to an extremely negative view of oneself, and even to self-hatred. These feelings and beliefs can interfere with recognizing them as a symptom of depression because they seem so ...
The Latest Google Headlines on:
Major depression
[google_news title=”” keyword=”Major depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Fix the internet
- State accepting challenges fix broadband mapping errorson May 7, 2024 at 8:02 pm
New Mexico has been allocated nearly $700 million to connect unconnected or poorly connected areas in the state to broadband, but to make sure the right households are reaping the benefits of that ...
- Internet Votes for Favorite Beauty Hacks—Experts Share Their Takeson May 7, 2024 at 10:37 am
From DIY body scrubs to tips for curling lashes, we asked experts to give the verdict on these popular budget beauty hacks.
- Full repairs to damaged Red Sea internet cables delayed by Yemen political splitson May 7, 2024 at 9:03 am
The Yemeni government has granted permits for the repair of two out of three cables, but refused the third because of a dispute with one of the cable’s consortium members.
- 5 Ways to Fix the GTA V “Rockstar Game Services are Unavailable” Error on Windows PCson May 7, 2024 at 5:53 am
Here, we look at how you can fix Grand Theft Auto V’s “Rockstar game services are unavailable” error on Windows 11/10 PCs. Are you another player who can’t play GTA V or GTA Online because of that ...
- 9 Fixes for the "No Internet Secured" Error on Windows 10on May 6, 2024 at 3:35 am
Running into the "No Internet, secured" message? Fix this common wireless error with these tips and get back online.
- Give small businesses the ‘right to repair’on May 2, 2024 at 7:00 am
Thankfully, bipartisan members of Congress have introduced a commonsense proposal that would benefit small businesses and consumers: the Right to Equitable and Professional Auto Industry Repair Act.
- How to fix the Longbeard error in Sea of Thieveson May 2, 2024 at 6:56 am
Sea of Thieves the game’s server status Restart your modem and router: This can often fix temporary glitches with your internet connection. Change your DNS servers: Occasionally, using different DNS ...
- How to fix your internet connectionon May 2, 2024 at 1:34 am
The internet is more important than ever because it is our gateway to our daily lives. For example, most school works and jobs require online tools. It is so vital to modern people’s lives that ...
- Chuck Todd: The race to build a better internet — before it's too lateon May 1, 2024 at 2:00 am
Reality check: "Any person in the U.S., regardless of their immigration status, may be entitled to many of the same constitutional rights as U.S. citizens, including the right to due process and equal ...
- 5 Ways to Fix the Failed-to-Connect-to-Server Minecraft Error on Windows PCson April 30, 2024 at 9:25 am
This troubleshooting guide provides some possible resolutions for fixing the Minecraft error message that says, “Failed to connect to the server.” Are you seeking a fix for that server connectivity ...
The Latest Google Headlines on:
Fix the internet
[google_news title=”” keyword=”fix the internet” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]